FDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis Drug For Crohn's Disease
Omvoh (mirikizumab-mrkz) for moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for ...
FDA approves Omvoh for moderately to severely active Crohn's disease
The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...
Irish Examiner on MSN22h
Crohn's Disease and ulcerative colitis: Eating for good gut health
Eating a Mediterranean-style diet can help people manage IBD symptoms, and a new cookbook from Crohn's & Colitis Ireland ...
WISH-TV on MSN22h
FDA approves Lilly's Omvoh for Crohn's disease
Indianapolis-based Lilly announced Thursday that the U.S. Food and Drug Administration has approved Omvoh for the treatment ...
US FDA Approves Omvoh For Severe Crohn’s Disease Relief: All You Need To Know
The FDA has approved Omvoh (mirikizumab-mrkz) for treating moderately to severely active Crohn’s disease in adults. Clinical ...
Gay police captain was demoted for taking leave to care for newborn, DC lawsuit says
There’s so many examples of straight colleagues being able to start families, being able to take leave for sick relatives, ...
Teva price target raised to $30 from $23 at Piper Sandler
Piper Sandler raised the firm’s price target on Teva (TEVA) to $30 from $23 and keeps an Overweight rating on the shares after meeting with ...
Massey University22h
Four academics awarded Health Research Council funding to further research
Four Te Kunenga ki Pūrehuroa Massey University research projects have been awarded Health Delivery Research Grants from the ...